Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

European Journal of Nuclear Medicine

Volumn 28, Issue 7, 2001, Pages 836-846

  Reubi, J C ^a   Waser, B ^a   Schaer, J C ^a   Laissue, J A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Human tissues; In vitro binding; Peptide receptors; Somatostatin receptor subtypes; Tumour targeting

Indexed keywords

ANGIOPEPTIN; CH 288; GROWTH HORMONE; L 779976; L 803087; L 817818; LIGAND; MESSENGER RNA; OCTREOTIDE; PENTETREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NEOPLASM; PROTEIN EXPRESSION;

AUTORADIOGRAPHY; HUMANS; IODINE RADIOISOTOPES; LIGANDS; NEOPLASMS; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION;

EID: 0034924612     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100541     Document Type: Article

References (42)

1. Multiple pathways of somatostatin action in neoplastic disease
2. Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging
3. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
4. Somatostatin and its receptor family
5. Classification and nomenclature of somatostatin receptors
6. Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 mRNAs in primary human tumors using in situ hybridization
7. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer
8. Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer
9. Immunohistochemical localization of somatostatin receptors sst2A in human tumors
10. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis
11. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas
12. Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: Membranous versus intracellular location
13. Development of a selective agonist at the somatostatin receptor subtype SSTR1
14. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
15. sst3-selective potent peptidic somatostatin receptor antagonists
16. Affinity profiles for human somatostatin receptor sst1-sst5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
17. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas
18. A selective analog for the somatostatin receptor subtype sst1 expressed by human tumors
19. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma
20. Human somatostatin receptor subtypes in acromegaly: Distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes
21. Expression of somatostatin receptor subtypes in human brain tumors
22. Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours
23. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas
24. Molecular pharmacology of somatostatin receptor subtypes
25. Somatostatin receptor gene expression in neuroblastoma
26. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours
27. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors
28. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A
29. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies
30. Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies
31. Somatostatin receptors in human prostate and prostate cancer
32. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: In vitro identification
33. High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers
34. Receptor nuclear medicine: Vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients
35. Analysis of somatostatin receptor subtype mRNA expression in human breast cancer
36. Somatostatin receptors subtype mRNA expression in human colorectal cancer and normal colic mucosa
37. Somatostatin receptor subtype gene expression in pituitary adenomas
38. Gene transcription of receptors for growth hormone-releasing peptide and somatostatin in human pituitary adenomas
39. Expression of three somatostatin receptor subtypes in pituitary adenomas: Evidence for preferential SSTR5 expression in the mammosomatotroph lineage
40. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2 and 5
41. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors